BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $442,000 | +14.5% | 5,000 | 0.0% | 0.01% | +8.3% |
| Q3 2021 | $386,000 | -53.7% | 5,000 | -50.0% | 0.01% | -64.7% |
| Q2 2021 | $834,000 | -71.3% | 10,000 | -74.0% | 0.03% | -73.8% |
| Q1 2021 | $2,907,000 | +63.3% | 38,500 | +64.5% | 0.13% | -11.6% |
| Q3 2020 | $1,780,000 | +0.2% | 23,400 | +62.5% | 0.15% | +21.5% |
| Q2 2020 | $1,776,000 | – | 14,400 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 240,400 | $19,922,000 | 0.01% |
| SIMPLEX TRADING, LLC | 43,900 | $3,637,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 33,900 | $2,809,000 | 0.00% |
| JPMORGAN CHASE & CO | 103,700 | $8,594,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |